Digital innovations are promoting HIV testing and prevention to MSM in Asia
Doravirine maintains higher rate of virological suppression over darunavir/ritonavir though 96 weeks of follow-up
Reduced dose darunavir/ritonavir effective and safe for people switching while virally suppressed
Three-quarters of deaths of people with HIV in London are due to non-AIDS conditions
Supervised drug consumption sites offer opportunities for HCV testing and treatment
HIV linked to higher risk of heart failure
Series of HIV outbreaks in people who inject drugs shows that ‘complacency is the new problem’
The kick that didn’t kill: first-ever randomised HIV cure study fails to eliminate infected cells
Civil society under threat: How can HIV advocates resist the impact?
